Clinical trial: Repurposed drug improves outcomes for patients with severe COVID-19 pneumonia
A drug commonly used to treat cystic fibrosis improved outcomes for patients with severe COVID-19 pneumonia and could be used to treat other respiratory infections, according to clinical trial results from researchers at ...
Jul 16, 2024
0
0